Open date: July 26th, 2021
Next review date: Thursday, Sep 30, 2021 at 11:59pm (Pacific Time)
Apply by this date to ensure full consideration by the committee.
Final date: Saturday, Oct 30, 2021 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
The University of California, Irvine (UCI), in partnership with the Grant Cooper Group, announces a national search for the Director of the UCI Institute for Clinical and Translational Science (ICTS). UCI is ranked 8th best public university in the nation and 35th among all American universities – public and private, according to the annual U.S. News & World Report "America's Best Colleges" 2020 survey. For the 20th consecutive year, U.S. News & World Report has recognized UCI Medical Center as one of America’s Best Hospitals.
The ICTS is the operational arm of our Clinical and Translational Science Award (CTSA) program, which was recently (2019) renewed by the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS). The Director will lead the ICTS ensuring that it enables the broad CTSA mission at our center (“hub”) as envisioned by the NIH. The Director will facilitate all categories of NIH funding made possible only to those institutions with funded CTSAs for training, special projects, supplemental grants, and translational research. Working with leaders across the institution, the Director will play an active role in increasing UCI’s portfolio of NIH funding by providing support, guidance, and oversight for applications that enhance the translational science mission of the ICTS and the CTSA program. The UCI ICTS has a stellar record of collaboration with the UCI Center for Clinical Research, the centralized clinical research unit (CCR) dedicated to the conduct of clinical trials, and the UCI Chao Family Comprehensive Cancer Center. In particular, the ICTS Director has facilitated the training and certification of the clinical research workforce (nursing associates, clinical coordinators, health science students, etc.), enhancing translational research career development of residents, fellows, and faculty in the SOM, and facilitated measures to study, evaluate, and improve the quality and efficiency of UC Irvine’s clinical research enterprise. Importantly, the ICTS has a collaborative leadership role in the CCR, and the CCR Director has a parallel role in the ICTS leadership. This synergy has made both units stronger.
UCI’s Susan & Henry Samueli College of Health Sciences is translating its tripartite mission to "discover, teach, heal," into the diverse healthcare workforce of the future and groundbreaking scientific discoveries. Creating a first-of-its-kind alliance across health disciplines, through team-based, interprofessional clinical research, teaching and healing, the college comprises the School of Medicine, the Sue & Bill Gross School of Nursing, the recently-launched School of Pharmacy & Pharmaceutical Sciences, the Program in Public Health (scheduled to be accredited in 2021), the Susan Samueli Integrative Health Institute, and research units focused on cancer, clinical translational science, precision health, and stem cells. In robust synergy with UCI Health, the only academic health system in Orange County, UCI is transforming education, discovery, and patient care to benefit the region, state, and nation. Together, the Susan & Henry Samueli College of Health Sciences and UCI Health form UCI Health Affairs, led by Vice Chancellor Steve Goldstein, MA, MD, PhD, FAAP.
Our search will identify outstanding candidates with exemplary administrative and academic leadership experience who are visionary, distinguished scholars and translational scientists, capable of leading the Institute and serving as principal investigator of the CTSA grant. The successful candidate will be a nationally recognized scholar and forward-thinking leader, one with a distinguished record of achievement in research, scholastic work, mentorship, team science, community outreach, and administration. Successful applicants will have the skills, knowledge, and resources necessary to lead the team as the Program Director/Principal Investigator.
Applicants should be established clinician-scientists who have the authority and influence necessary to successfully promote translational and clinical research locally, to partner with internal and external stakeholders, support the CTSA Program activities, and fully integrate the hub into the CTSA Program nationally. This includes authority, shared with other high-level institutional officials, over requisite space, protected time, promotions, contracting, conflict of interest, and staff qualification and certification. Qualified candidates should possess the knowledge, leadership, and administrative skills and capabilities necessary to direct those programs locally and to speak for the CTSA Program hub in national forums. This position will have an Academic appointment in a senate faculty position at the Associate or Full Professor level and will report to the school of medicine Dean by delegation from the Vice Chancellors of Research and Health Affairs. This position is being recruited in the following faculty titles, designation into the following title series will be dependent upon qualifications: Tenured Professor of Line series, Professor in Residence series or Professor of Clinical X series. Academic appointment will be determined based on the final candidate’s area of discipline.
Qualified candidates will have:
• Earned an MD, MD/PhD, or PhD (or equivalent) and be eligible for appointment as an associate or full professor.
• Demonstrated a record of scholarly productivity, significant history of independent NIH funding, and involvement in academic societies at a national level.
• Demonstrated leadership experience.
• Proven track-record of supporting high quality translational science and clinical research locally, regionally and nationally, and of fostering innovation in clinical research methods, training, and career development.
• Proven ability to work in a collaborative environment with other units involved in clinical research.
Application materials should include a curriculum vitae, a one-page letter of interest, and a separate statement that addresses past and potential contributions to diversity, equity and inclusion. Applicants may complete an online application profile and upload their CV and application materials electronically.
We desire applicants who have evidence of commitment to or strong potential for commitment to the advancement of diversity, equity, and inclusion for underrepresented minority students and groups (Black/African-American, Latino(a)/Chicano(a)/Hispanic, and Native American).
The University of California is committed to creating and maintaining a community dedicated to the advancement, application, and transmission of knowledge and creative endeavors through academic excellence, where all individuals who participate in University programs and activities can work and learn together in a safe and secure environment, free of violence, harassment, discrimination, exploitation, or intimidation. With this commitment as well as a commitment to addressing all forms of academic misconduct, UC Irvine conducts institutional reference checks for candidates finalists to whom the department or other hiring unit would like to extend a formal offer of appointment into Ladder Rank Professor or Professor of Teaching series, at all ranks (i.e., assistant, associate, and full). The institutional reference checks involve contacting the administration of the applicant’s previous institution(s) to ask whether there have been substantiated findings of misconduct that would violate the University’s Faculty Code of Conduct. To implement this process, UC Irvine requires all candidates of Ladder Rank Professor or Professor of Teaching series, at all ranks (i.e., assistant, associate, and full) to complete, sign, and upload the form entitled “Authorization to Release Information” into AP RECRUIT as part of their application. If the candidate does not include the signed authorization to release information with the application materials, the application will be considered incomplete. As with any incomplete application, the application will not receive further consideration. Although all applicants for faculty recruitments must complete the entire application, only finalists (i.e., those to whom the department or other hiring unit would like to extend a formal offer) considered for Ladder Rank Professor or Professor of Teaching series, at all ranks (i.e., assistant, associate, and full) positions will be subject to institutional reference checks.
Applications or nominations of appropriate candidates may be sent to:
Corey Lohnes, Managing Director, Grant Cooper
Application review will begin immediately and continue until the position has been filled.
MD, MD/PhD, PhD (or equivalent)
Curriculum Vitae - Your most recently updated C.V.
Statement of Research
Teaching Statement - See our guidance for writing a reflective teaching statement.
Inclusive Excellence Activities Statement - Statement addressing how past and/or potential contributions to inclusive excellence will advance UCI's Commitment to Inclusive Excellence. See our guidance for writing an inclusive excellence activities statement.
Authorization to Release Information Form - A reference check will be completed only if you are made a tentative offer to a Professor or Professor of Teaching series, at any rank. Download, complete, sign, and upload the form: https://ap.uci.edu/wp-content/uploads/AuthReleaseForm.pdf
Misc / Additional (Optional)
- 3-5 required (contact information only)
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.